Fundraising Fox

Longevity Investors & VC Firms in United States

114 firms in this list, with a median first check of $500K. 31 of them lead rounds. Generated from verified public data and updated continuously.

Blackstone Life Sciences
New YorkSeries A–Late Stage$20M – $60M
9 people
BOLD Longevity
BostonGrowth–Late Stage
9 people
Averin Capital
New YorkSeed–Growth
9 people
Fab Co-Creation Studio Ventures
San FranciscoPre-Seed–Series A$250K – $1M
1 person
InnoCom Bio Equities
San FranciscoPre-Seed–Series A
9 people
Snatched Ventures
San FranciscoPre-Seed–Series A
4 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
naturalX Health Ventures
KarlsruheSeed–Late Stage$3.2M – $5.4M
5 people
H Venture Partners
CincinnatiSeed–Late Stage$250K – $5M
2 people
Noetic
Toronto, OntarioSeed–Series A
2 people
1843 Capital
WashingtonSeed–Series B
7 people
Wildwood Ventures
BoulderPre-Seed–Series A
6 people
Sure Ventures
Silicon ValleyPre-Seed–Series A
10 people
Mammoth Research
Fort WayneSeries A–Growth
9 people
Ten VC
Menlo ParkPre-Seed–Seed$250K – $1.5M
1 person
InVivium Capital
ChicagoSeed–Late Stage
6 people
Generator Ventures
El Dorado HillsSeed–Series B
4 people
High Street Equity Partners
WashingtonPre-Seed–Seed$10K – $250K
2 people
Dementia Discovery
LondonPre-Seed–Series C
6 people
Flintera
Seed–Late Stage$10M – $60M
3 people
Carbon Silicon
Carson CityPre-Seed–Series A$100K – $500K
1 person
Gore Range Capital
SouthlakeSeed–Late Stage$500K – $5M
3 people
Deep Knowledge Group
LondonSeed
7 people
Seido Capital
BrusselsPre-Seed–Late Stage$270K – $2.7M
3 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.